Random things about me…
- I married a pretty girl from Corsica
- Corsica is the most beautiful place in the world, in my opinion
- The Paris-Brest is my favorite dessert
Bruno brings 25 years of experience in the life sciences industry, healthcare technology solutions, data science and analytics, at a global level, initially in Europe, then in the USA for the last 10 plus years.
Recently a Senior Vice President and General Manager at SHYFT Analytics, Bruno joins Carevive from Acorn AI, a Medidata company, a global respected leader of clinical data and patient-centric trial solutions.
Before joining Medidata, Bruno was CEO of Inflexxion, a technology software SaaS solutions company with clinical assessment tools, Real World Clinical Data and predictive analytics to healthcare organizations, providers, payers, life science companies and regulatory authorities in the space of substance use disorders. Prior to that, Bruno spent 20 years at Cegedim, growing and leading their Data and Research division.
Passionate about data and research, Bruno pioneered the Real-World Evidence & Real-World Data, and healthcare big data domain with the early development of collection and utilization of Longitudinal Patient Data sourced from Electronic Medical Records (EMR), in Europe and the US.
Bruno earned a BS in International Trade, and a Master’s degree in marketing, Market Research and Entrepreneurship at Novancia Business School Paris.
Why I Joined Carevive
I lost my mother to Breast Cancer almost 5 years ago, and back then, I felt useless and frustrated to not being able to help her feel better as she was suffering so much.
When I met our Founder, Maddy, I was right away thrilled by her vision and wanted to be a part of this incredible journey. Now that I joined Carevive Family, I feel lucky to work closely with Maddy, and to lead such an amazing team with unique skills and expertise in the field of Cancer. I know I am now in a position to support the different stakeholders involved in helping patients during their journey with cancer, and eventually improve their experience for better outcomes.
With combining our unique Technology, Data and Science, we will contribute to make cancer care better for patients and their families, and this is a really enriching and exciting experience!Linked In